Hawk Kim

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim et al. · Blood · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacology +11

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Je‐Hwan Lee, Young‐Don Joo, Hawk Kim et al. · Blood · 2011 · 147 citations · Full text

Medicine, Hematology, Oncology +14

Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine

Je‐Hwan Lee, Young‐Don Joo, Hawk Kim et al. · Journal of Clinical Oncology · 2012 · 117 citations

Medicine, Hematology, Immunology +9

Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type

Jae‐Cheol Jo, Misung Kim, Yunsuk Choi et al. · Annals of Hematology · 2016 · 111 citations

Veterinary Medicine, Cancer Biology, Oncology +15

Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Je‐Hwan Lee, Hawk Kim, Young‐Don Joo et al. · Journal of Clinical Oncology · 2017 · 85 citations

Medicine, Oncology, Pharmacotherapy +15